AzTrials
AzTrials

Weaning From Mechanical VentilationNCT07337408

Characterization of Weaning Practices in ICUs of Global South Countries

An observational study of Weaning From Mechanical Ventilation and Weaning Failure, run by Hospital do Coracao at 1 site in Brazil.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

This is a prospective observational study to be conducted in intensive care units of Global South countries. Patients on mechanical ventilation for more than 12 hours who have initiated the weaning process and for whom the attending team plans extubation within the next 6 hours will be included. Read more about this study

Who is it for?
Ages 18 years and older
How many people
900 participants
Where
1 siteBrazil
Study dates
25 May 2026to Apr 2027
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients receiving mechanical ventilation for more than 12 hours who are planning to undergo the first separation attempt from the invasive mechanical ventilation (as defined in the WIND Classification) in the next 6 hours or that has undergone a separation attempt less than 2 hours ago will be included.

Who may be able to join

  • Age > 18 years.
  • Receiving care at an intensive care unit.
  • Endotracheal intubation.
  • Mechanical ventilation for 12 hours or more.
  • First separation attempt, as defined in the WIND Classification - "Separation attempt from mechanical ventilation: an spontaneous breathing trial with or without extubation, or an extubation directly performed without identified spontaneous breathing trial (whatever the type: planned or unplanned extubation)" - planned to occur in the next 6 hours or that occurred less than 2 hours ago.

Who cannot join

  • Patients with prior extubation failure.
  • Patients with prior spontaneous breathing trial failure.
  • Patients unable to obey commands.
  • Neuromuscular disease or cervical spinal cord injury.
  • Tracheostomy.
  • Do-not-resuscitate order or contraindication for reintubation.
Show all 9Show fewer
  • Lack of informed consent.
  • Terminal extubation.
  • Previously included in the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Brazil1 site, 1 recruiting
  • Centro Hospitalar Unimed Joinville

    Joinville, Santa Catarina

    Braz Pereira, 55 47 99181-8400, linibp@hotmail.com

    Recruiting

Other trials in Brazil

About this study

Official title: Characterization of Weaning Practices in ICUs of Global South Countries: A Prospective Observational Study

This is a prospective observational study to be conducted in intensive care units of Global South countries. Patients on mechanical ventilation for more than 12 hours who have initiated the weaning process and for whom the attending team plans extubation within the next 6 hours will be included. Data will be collected for each patient during the first 7 days after extubation, with follow-up until hospital discharge or death. We plan to conduct the study in intensive care units from Global South countries (low- and middle-income countries predominantly located in the Southern Hemisphere, though some in the Northern Hemisphere are also considered).

Keywords
Weaning from mechanical ventilation, Weaning Failure, Weaning from mechanical ventilation, extubation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Extubation failure within 7 days.

    Defined as reintubation or death within 7 days after extubation.

    Measured: 7 days.

Secondary outcomes (8)
  1. Extubation within 28 days.

    Defined as extubation within 28 days after first separation attempt.

    Measured: 28 days.

  2. Intensive care unit length of stay.

    Defined as the number of days from the time of first separation attempt until discharge from the intensive care unit.

    Measured: At intensive care unit discharge, up to 28 days.

  3. Hospital length of stay.

    Defined as the number of days from the time of first separation attempt until discharge from the hospital.

    Measured: At hospital discharge, up to 28 days.

  4. Reintubation or death within 28 days.

    Defined as composite criterion of reintubation or death within 28 days after first separation attempt.

    Measured: 28 days.

  5. Intensive care unit mortality.

    Defined as mortality from the time of first separation attempt until discharge from the intensive care unit.

    Measured: At intensive care unit discharge, up to 28 days.

  6. Hospital mortality.

    Defined as mortality from the time of first separation attempt until discharge from the hospital.

    Measured: At hospital discharge, up to 28 days.

  7. Number of spontaneous breathing trials.

    Defined as the number of spontaneous breathing trials performed after first separation attempt.

    Measured: 28 days.

  8. WIND classification.

    Group 1 (short weaning): the first separation attempt resulted in a termination of the weaning process within 24 hours (successful separation or early death). • Group 2 (difficult weaning): weaning was terminated after more than 1 day but in less than 1 week after the first separation attempt (successful separation or death). • Group 3 (prolonged weaning): weaning was still not terminated 7 days after the first separation attempt (by success or death).

    Measured: 28 days.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2026
  2. Study start25 May 2026
  3. Primary completionMar 2027 (estimated)
  4. Study completionApr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
900 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07337408
Sponsor's protocol ID
GS Wean - Observational
Status last verified
Sep 2026
First submitted
23 Dec 2025
Last updated
23 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in